Abnormal vaginal bleeding after epidural steroid injection: a paired observation cohort study


      The use of epidural steroid injections has increased dramatically, but knowledge of potential adverse effects is lacking. An association between steroid injection and subsequent abnormal vaginal bleeding has been suspected clinically, but evidence has been limited to anecdotal reports.

      Study Design

      Paired observational retrospective cohort study using electronic medical records from a large integrated health care system. Participants were all nonhysterectomized women who underwent epidural steroid injections in 2011. For each steroid injection, encounters for abnormal vaginal bleeding during the 60 days preceding and 60 days after the injection were compared as paired observations. For women found to have bleeding, medical records review was performed to examine menopausal status and bleeding evaluation outcomes.


      Among 8166 epidural steroid injection procedures performed on 6926 nonhysterectomized women, 201 (2.5%) procedures were followed by at least 1 outpatient visit for abnormal vaginal bleeding. Women were 2.8 times more likely to present with abnormal vaginal bleeding during the postinjection period compared with the preinjection period (P < .0001). Of the 197 women with postinjection bleeding, 137 (70%) were premenopausal and 60 (30%) were postmenopausal. Postinjection bleeding prompted endometrial biopsy evaluation in 103 (52%) cases, with benign findings for 100% of premenopausal women (59/59) and 95% of postmenopausal women (42/44).


      Epidural steroid injections are associated with subsequent abnormal vaginal bleeding for both premenopausal and postmenopausal women. Women undergoing epidural steroid injection should be advised of abnormal bleeding as a potential adverse effect and providers should be aware of this association when evaluating abnormal bleeding.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Manchikanti L.
        • Falco F.J.
        • Singh V.
        • et al.
        Utilization of interventional techniques in managing chronic pain in the medicare population: analysis of growth patterns from 2000 to 2011.
        Pain Physician. 2012; 15: E969-E982
        • Manchikanti L.
        • Pampati V.
        • Boswell M.
        • Smith H.
        • Hirsch J.
        Analysis of the growth of epidural injections and costs in the Medicare population: a comparative evaluation of 1997, 2002, and 2006 data.
        Pain Physician. 2010; 13: 199-212
        • Manchikanti L.
        Role of neuraxial steroids in interventional pain management.
        Pain Physician. 2002; 5: 182-199
        • Gitkind A.I.
        • Shah B.
        • Thomas M.
        Epidural corticosteroid injections as a possible cause of menorrhagia: a case report.
        Pain Med. 2010; 11: 713-715
        • Çok O.Y.
        • Eker H.E.
        • Çok T.
        • et al.
        Abnormal uterine bleeding: Is it an under-reported side effect after epidural steroid injection for the management of low back pain?.
        Pain Med. 2011; 12: 986
        • Hirsch J.
        • Hsu E.
        Abnormal uterine bleeding following lumbar epidural corticosteroid injections and facet medial branch blocks in both pre- and postmenopausal women: a case series.
        Pain Med. 2012; 13: 1137-1140
        • Cunningham G.R.
        • Caperton Jr., E.M.
        • Goldzieher J.W.
        Antiovulatory activity of synthetic corticoids.
        J Clin Endocrinol Metab. 1975; 40: 265-267
        • Cunningham G.R.
        • Goldzieher J.W.
        • de la Pena A.
        • Oliver M.
        The mechanism of ovulation inhibition by triamcinolone acetonide.
        J Clin Endocrinol Metab. 1978; 46: 8-14
        • Carson T.E.
        • Daane T.A.
        • Lee P.A.
        • Tredway D.R.
        • Wallin J.D.
        Effect of intramuscular triamcinolone acetonide on the human ovulatory cycle.
        Cutis. 1977; 19: 633-637
        • Van der Windt D.
        • Koes B.
        • Deville W.
        • Boeke A.
        • de Jong B.
        • Bouter L.
        Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial.
        BMJ. 1998; 317: 1292-1296
        • Kurman R.J.
        Blaustein's Pathology of the Female Genital Tract4th edition.
        Springer Verlag, New York, NY1994: 378
        • Kurman R.J.
        Blaustein's Pathology of the Female Genital Tract4th edition.
        Springer Verlag, New York, NY1994: 380-384
        • Adelanto J.M.
        • Rees M.R.P.
        • Lopez B.A.
        • Turnbull A.C.
        Increased uterine prostaglandin E receptors in menorrhagic women.
        Br J Obstet Gynaecol. 1988; 95: 162-165
        • Cameron I.T.
        • Kelly R.W.
        • Baird D.R.
        Prostaglandins in the human uterus: an interaction between endometrium and myometrium.
        Prostaglandins Leukotrienes Med. 1985; 17: 329
        • Rybo G.
        Plasminogen activators in the endometrium. II: clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.
        Acta Obstet Gynecol Scand. 1966; 45: 429-450
      1. National Institute on Aging—Menopause. Available at: Accessed Nov. 1, 2012.